VEGFA and macular retinal edema: As intravitreous anti-vascular endothelial growth factors (anti-VEGF) injections have become the first-line therapy for DME [9,10], OCT patterns used in monitoring the effect of therapies for macular edema contribute to understanding the retinal anatomical response and structure damage of DME with distinctive aspects in each morphologic subtype [8].